Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-11

FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Zidovudine (AZT) by Aurobindo Pharma Limited. This approval supports a generic Zidovudine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zidovudine (Zidovudine)

Snippet

SUPPL AP for ZIDOVUDINE (ZIDOVUDINE)